Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Srini V Kaveri

Showing results (1-10 of 142) with videos related to

Pageof 15
Sort By:
Bulletin De L'Academie Nationale De Medecine|December 25, 2012
[Mechanisms of action of intravenous immunoglobulins]Srini V Kaveri
Autoimmunity Reviews|February 22, 2012
Intravenous immunoglobulin: exploiting the potential of natural antibodiesSrini V Kaveri
Trends in Pharmacological Sciences|September 12, 2018
Kill 'Em All: Efgartigimod Immunotherapy for Autoimmune DiseasesJagadeesh Bayry, Srini V Kaveri
International Immunology|July 2, 2017
IVIG-mediated effector functions in autoimmune and inflammatory diseasesCaroline Galeotti, Srini V Kaveri, Jagadeesh Bayry
Cell Host & Microbe|November 11, 2016
Tackling Difficult Staphylococcus aureus Infections: Antibodies Show the WayBo Shopsin, Srini V Kaveri, Jagadeesh Bayry
Clinical & Translational Immunology|October 22, 2020
Intravenous immunoglobulin immunotherapy for coronavirus disease-19 (COVID-19)Caroline Galeotti, Srini V Kaveri, Jagadeesh Bayry
Trends in Molecular Medicine|February 15, 2015
Molecular and immunological biomarkers to predict IVIg responseCaroline Galeotti, Srini V Kaveri, Jagadeesh Bayry
Autoimmunity Reviews|March 8, 2011
Comparison of different IVIg preparations on IL-17 production by human Th17 cellsMohan S Maddur, Srini V Kaveri, Jagadeesh Bayry
Trends in Pharmacological Sciences|May 25, 2015
IVIg for relapsing-remitting multiple sclerosis: promises and uncertaintiesJagadeesh Bayry, Hans-Peter Hartung, Srini V Kaveri
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2012
Natural IgM in immune equilibrium and harnessing their therapeutic potentialSrini V Kaveri, Gregg J Silverman, Jagadeesh Bayry
Pageof 15

Showing results (1-10 of 142) with videos related to

Sort By:
Pageof 15
Bulletin De L'Academie Nationale De Medecine|December 25, 2012
[Mechanisms of action of intravenous immunoglobulins]Srini V Kaveri
Autoimmunity Reviews|February 22, 2012
Intravenous immunoglobulin: exploiting the potential of natural antibodiesSrini V Kaveri
Trends in Pharmacological Sciences|September 12, 2018
Kill 'Em All: Efgartigimod Immunotherapy for Autoimmune DiseasesJagadeesh Bayry, Srini V Kaveri
International Immunology|July 2, 2017
IVIG-mediated effector functions in autoimmune and inflammatory diseasesCaroline Galeotti, Srini V Kaveri, Jagadeesh Bayry
Cell Host & Microbe|November 11, 2016
Tackling Difficult Staphylococcus aureus Infections: Antibodies Show the WayBo Shopsin, Srini V Kaveri, Jagadeesh Bayry
Clinical & Translational Immunology|October 22, 2020
Intravenous immunoglobulin immunotherapy for coronavirus disease-19 (COVID-19)Caroline Galeotti, Srini V Kaveri, Jagadeesh Bayry
Trends in Molecular Medicine|February 15, 2015
Molecular and immunological biomarkers to predict IVIg responseCaroline Galeotti, Srini V Kaveri, Jagadeesh Bayry
Autoimmunity Reviews|March 8, 2011
Comparison of different IVIg preparations on IL-17 production by human Th17 cellsMohan S Maddur, Srini V Kaveri, Jagadeesh Bayry
Trends in Pharmacological Sciences|May 25, 2015
IVIg for relapsing-remitting multiple sclerosis: promises and uncertaintiesJagadeesh Bayry, Hans-Peter Hartung, Srini V Kaveri
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2012
Natural IgM in immune equilibrium and harnessing their therapeutic potentialSrini V Kaveri, Gregg J Silverman, Jagadeesh Bayry
Pageof 15